Menu

BeyondSPX has rebranded as EveryTicker. We now operate at everyticker.com, reflecting our coverage across nearly all U.S. tickers. BeyondSPX has rebranded as EveryTicker.

Price Performance Heatmap

5Y Price (Market Cap Weighted)

All Stocks (1093)

Company Market Cap Price
NEO NeoGenomics, Inc.
They provide comprehensive laboratory testing services and advisory support for oncology diagnostics.
$1.18B
$9.15
+0.55%
AZTA Azenta, Inc.
Azenta's automated sample storage and cryogenic systems fall under Medical Devices & Biometrics.
$1.15B
$25.14
+0.04%
KMTS KESTRA MEDICAL TECHNOLOGIES, LTD.
Core product is Cardiology devices: wearable defibrillator (ASSURE WCD) and related cardiac therapy platform.
$1.15B
$22.29
TIC TIC Solutions, Inc.
Laboratory Testing & Advisory Services aligns with Acuren's lab-based destructive testing capabilities and analytical advisory work.
$1.13B
$9.23
+0.38%
SPRY ARS Pharmaceuticals, Inc.
Neffy includes a needle-free delivery device, aligning with Medical Devices & Biometrics.
$1.10B
$11.36
+1.88%
ALNT Allient Inc.
Medical Device Components align with Allient’s product capabilities used in medical device applications.
$1.08B
$61.27
-3.59%
BFLY Butterfly Network, Inc.
Core ultrasound imaging hardware and point-of-care devices (POCUS) produced by Butterfly.
$1.02B
$3.71
-7.94%
XERS Xeris Biopharma Holdings, Inc.
Prefillable Syringes describe a major packaging format used for injectable drugs in Xeris's portfolio.
$1.01B
$6.09
+0.41%
BLFS BioLife Solutions, Inc.
Sells consumables such as hPL, CellSeal vials, and CryoCase used within CGT workflows.
$995.22M
$20.20
-2.27%
PCRX Pacira BioSciences, Inc.
IOvera is a medical device product, placing Pacira in the Medical Devices & Biometrics category.
$983.47M
$22.83
-0.13%
CDNA CareDx, Inc
Directly provides Laboratory Testing & Advisory Services through its testing portfolio and diagnostic operations.
$980.31M
$18.85
-1.10%
MRVI Maravai LifeSciences Holdings, Inc.
Biologics safety testing kits and related analytical services (e.g., residual DNA quantification, Protein L assays) are direct BST offerings.
$976.80M
$3.77
-1.18%
MEG Montrose Environmental Group, Inc.
Laboratory testing and advisory services as part of Montrose's measurement and analysis offerings.
$963.30M
$27.04
-0.81%
STAA STAAR Surgical Company
STAAR directly manufactures ophthalmic medical devices, primarily implantable lenses (EVO ICL) used for vision correction.
$956.04M
$18.18
-5.41%
THRM Gentherm Incorporated
Medical devices & biometrics including patient temperature management devices.
$938.34M
$30.41
-1.07%
OPK OPKO Health, Inc.
OPKO's BioReference segment provides laboratory testing and advisory services.
$921.24M
$1.19
-1.25%
AMPH Amphastar Pharmaceuticals, Inc.
Inhalation systems and advanced formulations imply medical device components bridging drug delivery.
$917.21M
$19.88
-0.43%
SSII SS Innovations International, Inc.
Core product: robotic surgical system and endo-surgical instruments (SSi Mantra and related tools) sold as surgical equipment.
$892.44M
$4.79
+3.80%
INMD InMode Ltd.
InMode's core business is medical devices and biometrics, with RF-based aesthetic platforms and related systems.
$857.70M
$13.49
-0.48%
CSTL Castle Biosciences, Inc.
Provides laboratory-based molecular diagnostic testing and related advisory services directly to clinicians.
$822.24M
$28.00
-0.60%
IART Integra LifeSciences Holdings Corporation
Direct neurosurgery devices and surgical implants (e.g., CerebroFlo EVD catheter, Aurora Surgiscope) are core products.
$809.30M
$9.86
-5.10%
MATW Matthews International Corporation
Memorialization segment includes embalming chemicals and funeral supplies (memorialization products).
$805.00M
$25.82
-1.22%
PSNL Personalis, Inc.
NeXT Personal is a tumor-informed liquid biopsy-based MRD test, central to PSNL's offerings.
$793.02M
$8.68
-2.86%
CLB Core Laboratories N.V.
CLB provides laboratory testing and advisory services via proprietary tracers and reservoir analysis capabilities.
$775.62M
$16.15
-2.36%
AHG Akso Health Group
Sale of medical devices and biometrics hardware.
$746.25M
$1.36
+0.47%
MDXG MiMedx Group, Inc.
Directly manufactures and sells wound care devices and placental tissue allografts (EPIFIX, EPICORD, EPIEFFECT) used in wound healing.
$713.85M
$4.86
+0.73%
BVS Bioventus Inc.
Bioventus designs and manufactures medical devices and biometrics solutions for musculoskeletal health.
$700.29M
$9.17
+8.26%
TCMD Tactile Systems Technology, Inc.
Core medical devices for lymphedema and airway clearance (Flexitouch Plus, Nimbl, AffloVest) are manufactured and sold by the company.
$673.86M
$29.66
-1.67%
CBLL CeriBell, Inc.
Ceribell's core product is a point-of-care diagnostic EEG system (diagnostic equipment).
$659.19M
$17.87
+0.56%
AVNS Avanos Medical, Inc.
Avanos produces surgical equipment including radiofrequency ablation (RFA) systems and related devices used in procedures.
$644.29M
$13.59
-2.09%
SIBN SI-BONE, Inc.
SI-BONE operates as a medical device company that designs, develops and sells orthopedic implants and related medical devices.
$638.29M
$14.21
-3.43%
DBVT DBV Technologies S.A.
Viaskin patch is a medical device delivering therapy; categorize under Medical Devices & Biometrics.
$624.33M
$22.32
-2.06%
VPG Vishay Precision Group, Inc.
Medical infusion pump design win indicates participation in the Medical Devices & Biometrics market.
$623.85M
$46.55
-0.90%
SRDX Surmodics, Inc.
Surmodics' vascular intervention devices (SurVeil DCB, Pounce thrombectomy, Sublime radial access) are a core product category sold by the company.
$614.58M
$42.98
NUTX Nutex Health, Inc.
Nutex Health operates micro-hospitals and provides hospital services including acute inpatient care and emergency/observation services.
$603.54M
$105.30
-2.90%
KE Kimball Electronics, Inc.
KE's medical device and biometrics manufacturing capabilities are central to its strategy.
$597.99M
$24.14
-1.77%
CTKB Cytek Biosciences, Inc.
Cytek's instrument manufacturing includes flow cytometry diagnostic equipment, the core product line referenced in the article.
$563.88M
$4.47
+1.36%
EMBC Embecta Corp.
Embecta operates as a medical device company focused on insulin injection devices, including pen needles, syringes, and safety products.
$562.31M
$9.46
-1.51%
VREX Varex Imaging Corporation
Core Medical Imaging category representing imaging hardware and components used in medical devices.
$542.52M
$12.79
-1.73%
ZIMV ZimVie Inc.
Dental Equipment—ZimVie directly designs and sells dental hardware used in clinics (implants, imaging, CAD/CAM, etc.).
$530.23M
$18.99
CRMD CorMedix Inc.
DefenCath is an FDA-approved antimicrobial catheter-lock device marketed by CorMedix.
$515.82M
$6.92
-4.02%
MLAB Mesa Laboratories, Inc.
Clinical Genomics hardware (MassARRAY) is diagnostic equipment used in regulated lab environments, fitting Diagnostic Equipment.
$512.64M
$89.44
-3.65%
OFIX Orthofix Medical Inc.
Broad investable theme capturing medical devices and biometric sensing products, aligning with Orthofix's medical device offerings.
$509.65M
$12.51
-2.84%
← Previous
1 ... 3 4 5 6 7 ... 11
Next →
Showing page 5 of 11 (1093 total stocks)

Loading company comparison...

Loading research report...

AZTA Azenta, Inc.

Azenta Completes £20.5 Million Acquisition of UK Biocentre, Expanding European Sample‑Management Hub

Mar 04, 2026
STAA STAAR Surgical Company

STAAR Surgical Reports Fourth‑Quarter and Fiscal 2025 Results, Misses Revenue and EPS Estimates

Mar 04, 2026
BFLY Butterfly Network, Inc.

Butterfly Network Beats Q4 2025 Earnings, Surpasses Revenue and EPS Estimates

Feb 27, 2026
CTKB Cytek Biosciences, Inc.

Cytek Biosciences Reports Q4 2025 Results: Revenue Beats Estimates, EPS Misses

Feb 27, 2026
OPK OPKO Health, Inc.

OPKO Health Reports Q4 2025 Earnings: Revenue Beats Estimates, Guidance Lowers 2026 Outlook

Feb 27, 2026
PSNL Personalis, Inc.

Personalis Reports Q4 2025 Loss, Highlights 400% Test Volume Growth, Sets 2026 Sales Guidance

Feb 27, 2026
IART Integra LifeSciences Holdings Corporation

Integra LifeSciences Reports Q4 2025 Earnings, Beats EPS, Provides 2026 Guidance

Feb 26, 2026
NEO NeoGenomics, Inc.

NeoGenomics Launches RaDaR ST Assay to Detect Molecular Residual Disease

Feb 26, 2026
STAA STAAR Surgical Company

STAAR Surgical Surpasses 4 Million Implantable Collamer Lenses Sold Worldwide

Feb 26, 2026
CBLL CeriBell, Inc.

CeriBell Reports Strong Q4 2025 Earnings, Beats Revenue Estimates

Feb 25, 2026
CDNA CareDx, Inc

CareDx Names Keith Kennedy as Chief Operating Officer and Chief Financial Officer

Feb 25, 2026
SIBN SI-BONE, Inc.

SI‑BONE Reports Record Q4 2025 Results, Beats EPS Estimate, and Provides 2026 Guidance

Feb 24, 2026
INMD InMode Ltd.

InMode Ends Review of Potential Transaction Proposals

Feb 23, 2026
NEO NeoGenomics, Inc.

NeoGenomics Reports Q4 and Full‑Year 2025 Results, Highlights Strong Clinical Growth and 2026 Guidance

Feb 18, 2026
TCMD Tactile Systems Technology, Inc.

Tactile Systems Technology Reports Q4 2025 Earnings Beat Estimates, Raises FY2026 Guidance

Feb 18, 2026
CDNA CareDx, Inc

CareDx Announces Pivotal Validation of AlloHeme™ AML/MDS Post‑Cell‑Therapy Surveillance Test

Feb 13, 2026
NEO NeoGenomics, Inc.

NeoGenomics Unveils PanTracer Pro, Expanding Integrated Oncology Diagnostics

Feb 12, 2026
BFLY Butterfly Network, Inc.

Butterfly Network Gains GovRAMP and TX‑RAMP Authorizations, Expanding U.S. Government Cloud Sales

Feb 11, 2026
PSNL Personalis, Inc.

Personalis Secures Medicare Coverage for Lung‑Cancer MRD Test, Expanding Access and Accelerating Diagnostics Shift

Feb 11, 2026
AZTA Azenta, Inc.

Azenta Expands into Space‑Based Life Sciences with Frontier Space Partnership

Feb 10, 2026
INMD InMode Ltd.

InMode Ltd. Reports Fourth‑Quarter and Full‑Year 2025 Financial Results

Feb 10, 2026
EMBC Embecta Corp.

Embecta Corp. Reports Q1 Fiscal 2026 Earnings: Revenue $261 M, EPS $0.71, Beat Estimates, Reaffirms Guidance

Feb 05, 2026
AZTA Azenta, Inc.

Azenta Reports First‑Quarter Fiscal 2026 Results: Revenue $149 M, EPS $0.09, Adjusted EBITDA Margin 8.5%

Feb 04, 2026
CDNA CareDx, Inc

CareDx to Present AlloHeme Validation Data at 2026 Tandem Meetings

Feb 04, 2026
MDXG MiMedx Group, Inc.

MiMedx Group Expands Product Portfolio with Exclusive Distribution Deal for Three Advanced Wound Care Products

Feb 04, 2026
OPK OPKO Health, Inc.

OPKO Health and Entera Bio Expand Partnership to Develop Oral Long‑Acting PTH Tablet for Hypoparathyroidism

Feb 04, 2026